Biologics Tech Transfer
A late-stage biologics program is moving from a donor site to a receiving CDMO ahead of launch. The technical package, analytical method transfer, comparability work, engineering lots, PPQ campaign, validation report, and CMC variation all have to clear in sequence. The calendar looks busy everywhere, but not every busy workstream protects the launch date.
Which transfer gate becomes the critical path, and what needs to move first so PPQ, validation, and launch-ready supply clear inside the transfer window?
The model treats tech transfer as a time-phased evidence pipeline with a launch-window supply commitment. Batch-equivalent work moves from donor package to method transfer, engineering runs, PPQ, validation/filing, and launch-ready supply. Queue nodes carry completed evidence month to month, while period-specific transfer, engineering, PPQ, validation, CMC, QC, QA, suite, and budget limits determine which gate can actually feed the next one.
- Engineering-run evidence gates PPQ
- PPQ campaign window is fully used
- Validation / CMC filing window binds at launch
The transfer only clears the launch window because donor package work, method transfer, and engineering evidence are pulled forward before PPQ and validation open up. The critical path is not donor support alone; it is the handoff from engineering evidence into the PPQ campaign and validation/CMC filing window.